2016 American Transplant Congress » Concurrent Session: Kidney: Induction Therapy 1

Date: Monday, June 13, 2016

Time: 2:30pm-4:00pm

Location: Room 312

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

2:30pm-2:42pm: Pre-Transplant IgM to Post-Transplant IgG DSA Conversion May Be Affected by Immunosuppression.

A. Nguyen,¹ M. Everly,¹ L. Rebellato,² C. Haisch,² K. Briley,² P. Bolin,² S. Kendrick,² C. Morgan,² A. Maldonado,² P. Terasaki.¹

2:42pm-2:54pm: Long-Term Outcomes of ATG versus IL-2 Receptor Antagonist in Low Risk Kidney Transplant Recipients: Donor Factors.

F. Al Ammary, S. Bae, A. Massie, N. Desai, N. Dagher, E. Kraus, A. Wiseman, D. Segev.

2:54pm-3:06pm: Everolimus (EVR) versus Mycophenolate Sodium (MPS) for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin (r-ATG) and Tacrolimus (TAC).

H. Tedesco-Silva,¹ C. Felipe,¹ A. Brigido,¹ A. Bessa,¹ M. Paula,¹ P. Ruppel,¹ M. Cristelli,¹ L. Viana,¹ G. Basso,¹ M. Franco,² W. Aguiar,¹ J. Medina-Pestana.¹

3:06pm-3:18pm: Earlier Repletion of Lymphocytes After Alemtuzumab Induction Is Associated with a Lower Incidence of Infection Following Renal Transplantation.

M. Willicombe, D. Goodall, A. McLean, D. Taube.

3:18pm-3:30pm: Induction Therapy with Rabbit Antithymocyte Globulin (rATG, Thymoglobulin^®) vs Basiliximab After Kidney Transplantation: A Health Economic Analysis from a German Perspective.

L. Cremaschi,¹ R. Thissen,² T. Benzing,² M. Wiesener,³ N. Zink,³ T. Paivanas,⁴ J. Reitan,⁴ M. Gallagher,⁵ F. Thaiss.¹

3:30pm-3:42pm: Evaluation of a Risk-Stratified Induction Immunosuppression Protocol Utilizing Low-Dose Antithymocyte Globulin in Renal Transplantation.

A. Diamond, Z. Khawaja, M. Simpson, S.-C. Kung, M. Akoad, J. Pomposelli, E. Pomfret.

3:42pm-3:54pm: B Cell Signature Profiling in Kidney Transplant Patients on Thymoglobulin.

A. Benitez,¹ T. Milford,² K. Torralba,³ K. Payne,² M. De Vera.¹

« View all sessions from the 2016 American Transplant Congress